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Rethinking the global tracking system on development 
assistance to reproductive, maternal, newborn, and child health 
Tracking of spending on reproductive, maternal, 
newborn, and child health (RMNCH) is key to monitoring 
progress towards Millennium Development Goals (MDGs) 
4 and 5 to reduce child mortality and improve maternal 
health. The Organisation for Economic Co-operation and 
Development’s development assistance committee tracks 
bilateral and multilateral oﬃ  cial development assistance 
(ODA) and other resource ﬂ ows, including private 
donors, such as the Bill & Melinda Gates Foundation1—
so-called ODA+—under the credit reporting system 
database. Commitments and disbursements are tracked 
at both the aggregate level and at the level of particular 
aid programmes. The importance of measurement 
of progress and ensuring accountability has been 
increasingly discussed after the Paris Declaration on Aid 
Eﬀ ectiveness. Within this context, in this issue of The 
Lancet Global Health, the new study by Leonardo Arregoces 
and colleagues2 is the latest in a long series of analyses on 
resource tracking of RMNCH,3,4 focusing on evaluating 
whether donor funding is well targeted to countries 
with the greatest need. In their comprehensive study, 
Arregoces and colleagues report that, although overall 
levels of ODA+ funding decreased, funding for RMNCH 
increased in 2011 and 2012.
External resources still account for 16·4% of total 
health spending in low-income countries and 9·5% 
in countries in Africa.5 This ﬁ nding has implications 
for the sustainability and fungibility of programmes 
and is vital to better understand the trend of the 
sources and level of supports.2,6 Despite a wealth of 
research based on available datasets, questions remain 
regarding the fragmentation of funding:6,7 how should 
aid be disbursed? What modality and approaches are 
most eﬀ ective—eg, project-oriented, general budget, 
or multisectoral in terms of outcomes and outputs? 
What is the linkage between disbursement and actual 
spending? This study provides a useful contribution to 
whether programme speciﬁ c-funding has been targeted 
to those countries with the greatest needs. Yet there 
remains room for more international eﬀ orts to further 
investigate the aforementioned questions. 
The study by Arregoces and colleagues2 raises the 
importance of harmonising international collaboration 
across various resource-tracking initiatives. This is 
welcome and highlights the need to ﬁ ll existing gaps 
and agree on a standardised method. The current credit 
reporting system method broadly categorises each fund 
and has limits as to diﬀ erent health-care activities—
for example, prevention and treatment of HIV/AIDS 
among pregnant women can be either categorised 
under maternal health or HIV/AIDS programmes. On 
the other hand, the Institute for Health Metrics and 
Evaluation excludes malaria, tuberculosis, and HIV/AIDS 
programmes from its estimate on aid for maternal, 
newborn, and child health. The assumptions around 
the allocation to RMNCH from general budget support 
could also be worthy of further examination. 
There is no doubting the importance of ODA in 
health generally, and more speciﬁ cally for RMNCH. 
Countries and external funds have competing priorities 
in allocating restricted funds. It is also important to 
ensure comprehensiveness, and the study rightly 
raises the issue of some of the data gaps. Eﬀ orts 
should be made to include all missing data, wherever 
possible, from countries that are not members of 
the development assistance committee (such as 
China and Middle Eastern countries), major donor 
non-governmental organisations, and foundations, 
to ensure that public and private inﬂ uences on the 
direction of ODA programmes are properly understood. 
For example, China contributes as much as US$4 billion 
in aid annually and is increasingly inﬂ uential in Africa,8 
but was not included in this study.2 On a similar note, 
understanding the roles of both external and domestic 
funding is vital—more than half of all RMNCH funding 
for the 75 Countdown countries comes from domestic 
sources.9 
The long-term goal of independence of recipients 
and sustainability of projects must remain at the 
forefront of all programmes. The post-2015 Sustainable 
Development Goals (SDGs) have been criticised as being 
too general and impractical,10 and as we move into the 
SDG era this study has identiﬁ ed a need for new funding 
pathways related to RMNCH.2 Here is a dilemma: the 
most important aspect of the SDG era is not only 
a chance for the global health community to work 
See Articles page e410
Comment
e351 www.thelancet.com/lancetgh   Vol 3   July 2015
together, but also the opportunity to connect sectors. 
This would include a possible move from currently 
dominant project-oriented funding to health system 
strengthening in which delivery of RMNCH services 
should be essential. Greater eﬀ orts are also needed to 
prevent donor aid from displacing national funding 
for programmes,11 and governments of developing 
countries must be more involved in global health 
initiatives,12 but such involvement and planning needs 
detailed and robust analysis. 
A wealth of studies exists for tracking ODA,1,3,4 but 
few go into any depth to analyse the linkages between 
ODA and outcomes or eﬀ ectiveness. The article by 
Arregoces and colleagues explores this area through its 
analysis of the relation between ODA+ on RMNCH and 
health outcomes in child mortality and other related 
health outcomes.2 This analysis leads the way for further 
research to be done to link more directly to outcomes, 
and to ﬁ nd innovative ways to analyse relations between 
programme funding, national funding, and delivery 
metrics. It also supports further development of more 
comprehensive and detailed tracking of resources 
through a health accounting framework.
The health of mothers, newborns, and children lies at 
the heart of a healthy productive society. Such a society 
will take enhanced, collaborative, and comprehensive 
eﬀ orts in research on all major funding sources linked 
with outcomes and eﬀ ective project and policy 
implementation. A comprehensive understanding of 
global aid ﬂ ows, and robust data supporting analyses 
such as this, is essential to ensure that ODA for health 
continues to be transparent, sustainable, and responsive 
to the goals of the global health community rather than 
the funding nations. Through better research we can 
build on the MDG experience to ensure that ODA works 
for their beneﬁ t in the SDG era.
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